nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—PTGS1—Etoposide—muscle cancer	0.146	0.254	CbGbCtD
Eletriptan—ABCB1—Dactinomycin—muscle cancer	0.101	0.176	CbGbCtD
Eletriptan—ABCB1—Vincristine—muscle cancer	0.0621	0.108	CbGbCtD
Eletriptan—ABCB1—Etoposide—muscle cancer	0.0569	0.0993	CbGbCtD
Eletriptan—ABCB1—Doxorubicin—muscle cancer	0.0388	0.0677	CbGbCtD
Eletriptan—ABCB1—Methotrexate—muscle cancer	0.0376	0.0656	CbGbCtD
Eletriptan—CYP3A4—Vincristine—muscle cancer	0.0372	0.0649	CbGbCtD
Eletriptan—CYP2D6—Doxorubicin—muscle cancer	0.0365	0.0638	CbGbCtD
Eletriptan—CYP3A4—Etoposide—muscle cancer	0.0341	0.0595	CbGbCtD
Eletriptan—CYP3A4—Doxorubicin—muscle cancer	0.0232	0.0406	CbGbCtD
Eletriptan—Decreased appetite—Dactinomycin—muscle cancer	0.000965	0.00226	CcSEcCtD
Eletriptan—Dysgeusia—Etoposide—muscle cancer	0.000964	0.00226	CcSEcCtD
Eletriptan—Hyperhidrosis—Vincristine—muscle cancer	0.000959	0.00224	CcSEcCtD
Eletriptan—Fatigue—Dactinomycin—muscle cancer	0.000958	0.00224	CcSEcCtD
Eletriptan—Back pain—Etoposide—muscle cancer	0.000953	0.00223	CcSEcCtD
Eletriptan—Pain—Dactinomycin—muscle cancer	0.00095	0.00222	CcSEcCtD
Eletriptan—Vascular purpura—Doxorubicin—muscle cancer	0.000948	0.00222	CcSEcCtD
Eletriptan—Muscle spasms—Etoposide—muscle cancer	0.000947	0.00222	CcSEcCtD
Eletriptan—Anorexia—Vincristine—muscle cancer	0.000946	0.00221	CcSEcCtD
Eletriptan—Eczema—Doxorubicin—muscle cancer	0.000944	0.00221	CcSEcCtD
Eletriptan—Eye pain—Doxorubicin—muscle cancer	0.00094	0.0022	CcSEcCtD
Eletriptan—Mood swings—Methotrexate—muscle cancer	0.000928	0.00217	CcSEcCtD
Eletriptan—Hypotension—Vincristine—muscle cancer	0.000927	0.00217	CcSEcCtD
Eletriptan—Ataxia—Methotrexate—muscle cancer	0.000921	0.00216	CcSEcCtD
Eletriptan—Feeling abnormal—Dactinomycin—muscle cancer	0.000915	0.00214	CcSEcCtD
Eletriptan—Ill-defined disorder—Etoposide—muscle cancer	0.000914	0.00214	CcSEcCtD
Eletriptan—Anaemia—Etoposide—muscle cancer	0.00091	0.00213	CcSEcCtD
Eletriptan—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000908	0.00212	CcSEcCtD
Eletriptan—Liver function test abnormal—Methotrexate—muscle cancer	0.000904	0.00212	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000904	0.00212	CcSEcCtD
Eletriptan—Increased appetite—Doxorubicin—muscle cancer	0.000903	0.00211	CcSEcCtD
Eletriptan—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000899	0.0021	CcSEcCtD
Eletriptan—Insomnia—Vincristine—muscle cancer	0.000897	0.0021	CcSEcCtD
Eletriptan—Paraesthesia—Vincristine—muscle cancer	0.000891	0.00208	CcSEcCtD
Eletriptan—Malaise—Etoposide—muscle cancer	0.000888	0.00208	CcSEcCtD
Eletriptan—Vertigo—Etoposide—muscle cancer	0.000885	0.00207	CcSEcCtD
Eletriptan—Leukopenia—Etoposide—muscle cancer	0.000882	0.00206	CcSEcCtD
Eletriptan—Purpura—Doxorubicin—muscle cancer	0.00088	0.00206	CcSEcCtD
Eletriptan—Abdominal pain—Dactinomycin—muscle cancer	0.000878	0.00205	CcSEcCtD
Eletriptan—Body temperature increased—Dactinomycin—muscle cancer	0.000878	0.00205	CcSEcCtD
Eletriptan—Loss of consciousness—Etoposide—muscle cancer	0.000866	0.00203	CcSEcCtD
Eletriptan—Decreased appetite—Vincristine—muscle cancer	0.000863	0.00202	CcSEcCtD
Eletriptan—Cough—Etoposide—muscle cancer	0.000859	0.00201	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Vincristine—muscle cancer	0.000857	0.002	CcSEcCtD
Eletriptan—Fatigue—Vincristine—muscle cancer	0.000855	0.002	CcSEcCtD
Eletriptan—Convulsion—Etoposide—muscle cancer	0.000853	0.002	CcSEcCtD
Eletriptan—Hypertension—Etoposide—muscle cancer	0.00085	0.00199	CcSEcCtD
Eletriptan—Constipation—Vincristine—muscle cancer	0.000849	0.00199	CcSEcCtD
Eletriptan—Pain—Vincristine—muscle cancer	0.000849	0.00199	CcSEcCtD
Eletriptan—Diplopia—Doxorubicin—muscle cancer	0.000848	0.00198	CcSEcCtD
Eletriptan—Osteoarthritis—Doxorubicin—muscle cancer	0.000848	0.00198	CcSEcCtD
Eletriptan—Asthma—Methotrexate—muscle cancer	0.000847	0.00198	CcSEcCtD
Eletriptan—Migraine—Doxorubicin—muscle cancer	0.000835	0.00195	CcSEcCtD
Eletriptan—Affect lability—Doxorubicin—muscle cancer	0.000835	0.00195	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000833	0.00195	CcSEcCtD
Eletriptan—Discomfort—Etoposide—muscle cancer	0.000828	0.00194	CcSEcCtD
Eletriptan—Face oedema—Doxorubicin—muscle cancer	0.000819	0.00192	CcSEcCtD
Eletriptan—Hypersensitivity—Dactinomycin—muscle cancer	0.000818	0.00191	CcSEcCtD
Eletriptan—Abdominal discomfort—Methotrexate—muscle cancer	0.000812	0.0019	CcSEcCtD
Eletriptan—Gastrointestinal pain—Vincristine—muscle cancer	0.000811	0.0019	CcSEcCtD
Eletriptan—Confusional state—Etoposide—muscle cancer	0.00081	0.0019	CcSEcCtD
Eletriptan—Mood swings—Doxorubicin—muscle cancer	0.000804	0.00188	CcSEcCtD
Eletriptan—Ataxia—Doxorubicin—muscle cancer	0.000798	0.00187	CcSEcCtD
Eletriptan—Asthenia—Dactinomycin—muscle cancer	0.000797	0.00186	CcSEcCtD
Eletriptan—Tachycardia—Etoposide—muscle cancer	0.000784	0.00184	CcSEcCtD
Eletriptan—Abdominal pain—Vincristine—muscle cancer	0.000784	0.00184	CcSEcCtD
Eletriptan—Body temperature increased—Vincristine—muscle cancer	0.000784	0.00184	CcSEcCtD
Eletriptan—Liver function test abnormal—Doxorubicin—muscle cancer	0.000783	0.00183	CcSEcCtD
Eletriptan—Skin disorder—Etoposide—muscle cancer	0.000781	0.00183	CcSEcCtD
Eletriptan—Erectile dysfunction—Methotrexate—muscle cancer	0.00078	0.00182	CcSEcCtD
Eletriptan—Dry skin—Doxorubicin—muscle cancer	0.000777	0.00182	CcSEcCtD
Eletriptan—Hyperhidrosis—Etoposide—muscle cancer	0.000777	0.00182	CcSEcCtD
Eletriptan—Abdominal pain upper—Doxorubicin—muscle cancer	0.000775	0.00181	CcSEcCtD
Eletriptan—Anorexia—Etoposide—muscle cancer	0.000766	0.00179	CcSEcCtD
Eletriptan—Diarrhoea—Dactinomycin—muscle cancer	0.00076	0.00178	CcSEcCtD
Eletriptan—Drowsiness—Methotrexate—muscle cancer	0.000755	0.00177	CcSEcCtD
Eletriptan—Hypotension—Etoposide—muscle cancer	0.000751	0.00176	CcSEcCtD
Eletriptan—Gastritis—Doxorubicin—muscle cancer	0.000751	0.00176	CcSEcCtD
Eletriptan—Muscular weakness—Doxorubicin—muscle cancer	0.000748	0.00175	CcSEcCtD
Eletriptan—Abdominal distension—Doxorubicin—muscle cancer	0.000738	0.00173	CcSEcCtD
Eletriptan—Stomatitis—Methotrexate—muscle cancer	0.000736	0.00172	CcSEcCtD
Eletriptan—Conjunctivitis—Methotrexate—muscle cancer	0.000734	0.00172	CcSEcCtD
Eletriptan—Dysphagia—Doxorubicin—muscle cancer	0.000733	0.00172	CcSEcCtD
Eletriptan—Asthma—Doxorubicin—muscle cancer	0.000733	0.00172	CcSEcCtD
Eletriptan—Influenza—Doxorubicin—muscle cancer	0.000733	0.00172	CcSEcCtD
Eletriptan—Hypersensitivity—Vincristine—muscle cancer	0.000731	0.00171	CcSEcCtD
Eletriptan—Sweating—Methotrexate—muscle cancer	0.000724	0.00169	CcSEcCtD
Eletriptan—Paraesthesia—Etoposide—muscle cancer	0.000722	0.00169	CcSEcCtD
Eletriptan—Dyspnoea—Etoposide—muscle cancer	0.000717	0.00168	CcSEcCtD
Eletriptan—Somnolence—Etoposide—muscle cancer	0.000715	0.00167	CcSEcCtD
Eletriptan—Angina pectoris—Doxorubicin—muscle cancer	0.000714	0.00167	CcSEcCtD
Eletriptan—Epistaxis—Methotrexate—muscle cancer	0.000712	0.00167	CcSEcCtD
Eletriptan—Asthenia—Vincristine—muscle cancer	0.000712	0.00167	CcSEcCtD
Eletriptan—Vomiting—Dactinomycin—muscle cancer	0.000706	0.00165	CcSEcCtD
Eletriptan—Bronchitis—Doxorubicin—muscle cancer	0.000705	0.00165	CcSEcCtD
Eletriptan—Rash—Dactinomycin—muscle cancer	0.0007	0.00164	CcSEcCtD
Eletriptan—Decreased appetite—Etoposide—muscle cancer	0.000699	0.00163	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Etoposide—muscle cancer	0.000694	0.00162	CcSEcCtD
Eletriptan—Fatigue—Etoposide—muscle cancer	0.000693	0.00162	CcSEcCtD
Eletriptan—Pain—Etoposide—muscle cancer	0.000687	0.00161	CcSEcCtD
Eletriptan—Constipation—Etoposide—muscle cancer	0.000687	0.00161	CcSEcCtD
Eletriptan—Diarrhoea—Vincristine—muscle cancer	0.000679	0.00159	CcSEcCtD
Eletriptan—Pollakiuria—Doxorubicin—muscle cancer	0.000677	0.00158	CcSEcCtD
Eletriptan—Pharyngitis—Methotrexate—muscle cancer	0.000673	0.00157	CcSEcCtD
Eletriptan—Urinary tract disorder—Methotrexate—muscle cancer	0.000669	0.00157	CcSEcCtD
Eletriptan—Weight increased—Doxorubicin—muscle cancer	0.000667	0.00156	CcSEcCtD
Eletriptan—Urethral disorder—Methotrexate—muscle cancer	0.000664	0.00155	CcSEcCtD
Eletriptan—Weight decreased—Doxorubicin—muscle cancer	0.000663	0.00155	CcSEcCtD
Eletriptan—Feeling abnormal—Etoposide—muscle cancer	0.000662	0.00155	CcSEcCtD
Eletriptan—Hyperglycaemia—Doxorubicin—muscle cancer	0.000661	0.00155	CcSEcCtD
Eletriptan—Nausea—Dactinomycin—muscle cancer	0.00066	0.00154	CcSEcCtD
Eletriptan—Gastrointestinal pain—Etoposide—muscle cancer	0.000657	0.00154	CcSEcCtD
Eletriptan—Dizziness—Vincristine—muscle cancer	0.000656	0.00154	CcSEcCtD
Eletriptan—Drowsiness—Doxorubicin—muscle cancer	0.000654	0.00153	CcSEcCtD
Eletriptan—Visual impairment—Methotrexate—muscle cancer	0.000653	0.00153	CcSEcCtD
Eletriptan—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000641	0.0015	CcSEcCtD
Eletriptan—Urticaria—Etoposide—muscle cancer	0.000639	0.00149	CcSEcCtD
Eletriptan—Stomatitis—Doxorubicin—muscle cancer	0.000637	0.00149	CcSEcCtD
Eletriptan—Abdominal pain—Etoposide—muscle cancer	0.000635	0.00149	CcSEcCtD
Eletriptan—Body temperature increased—Etoposide—muscle cancer	0.000635	0.00149	CcSEcCtD
Eletriptan—Conjunctivitis—Doxorubicin—muscle cancer	0.000635	0.00149	CcSEcCtD
Eletriptan—Tinnitus—Methotrexate—muscle cancer	0.000632	0.00148	CcSEcCtD
Eletriptan—Vomiting—Vincristine—muscle cancer	0.000631	0.00148	CcSEcCtD
Eletriptan—Sweating—Doxorubicin—muscle cancer	0.000627	0.00147	CcSEcCtD
Eletriptan—Rash—Vincristine—muscle cancer	0.000626	0.00146	CcSEcCtD
Eletriptan—Dermatitis—Vincristine—muscle cancer	0.000625	0.00146	CcSEcCtD
Eletriptan—Headache—Vincristine—muscle cancer	0.000622	0.00145	CcSEcCtD
Eletriptan—Epistaxis—Doxorubicin—muscle cancer	0.000617	0.00144	CcSEcCtD
Eletriptan—Sinusitis—Doxorubicin—muscle cancer	0.000613	0.00143	CcSEcCtD
Eletriptan—Immune system disorder—Methotrexate—muscle cancer	0.000612	0.00143	CcSEcCtD
Eletriptan—Chills—Methotrexate—muscle cancer	0.000608	0.00142	CcSEcCtD
Eletriptan—Alopecia—Methotrexate—muscle cancer	0.000599	0.0014	CcSEcCtD
Eletriptan—Bradycardia—Doxorubicin—muscle cancer	0.000597	0.0014	CcSEcCtD
Eletriptan—Hypersensitivity—Etoposide—muscle cancer	0.000592	0.00139	CcSEcCtD
Eletriptan—Nausea—Vincristine—muscle cancer	0.000589	0.00138	CcSEcCtD
Eletriptan—Rhinitis—Doxorubicin—muscle cancer	0.000588	0.00138	CcSEcCtD
Eletriptan—Hypoaesthesia—Doxorubicin—muscle cancer	0.000584	0.00137	CcSEcCtD
Eletriptan—Pharyngitis—Doxorubicin—muscle cancer	0.000582	0.00136	CcSEcCtD
Eletriptan—Urinary tract disorder—Doxorubicin—muscle cancer	0.00058	0.00136	CcSEcCtD
Eletriptan—Oedema peripheral—Doxorubicin—muscle cancer	0.000578	0.00135	CcSEcCtD
Eletriptan—Dysgeusia—Methotrexate—muscle cancer	0.000578	0.00135	CcSEcCtD
Eletriptan—Asthenia—Etoposide—muscle cancer	0.000577	0.00135	CcSEcCtD
Eletriptan—Urethral disorder—Doxorubicin—muscle cancer	0.000575	0.00135	CcSEcCtD
Eletriptan—Back pain—Methotrexate—muscle cancer	0.000571	0.00134	CcSEcCtD
Eletriptan—Pruritus—Etoposide—muscle cancer	0.000569	0.00133	CcSEcCtD
Eletriptan—Visual impairment—Doxorubicin—muscle cancer	0.000565	0.00132	CcSEcCtD
Eletriptan—Diarrhoea—Etoposide—muscle cancer	0.00055	0.00129	CcSEcCtD
Eletriptan—Ill-defined disorder—Methotrexate—muscle cancer	0.000547	0.00128	CcSEcCtD
Eletriptan—Tinnitus—Doxorubicin—muscle cancer	0.000547	0.00128	CcSEcCtD
Eletriptan—Anaemia—Methotrexate—muscle cancer	0.000545	0.00128	CcSEcCtD
Eletriptan—Flushing—Doxorubicin—muscle cancer	0.000545	0.00127	CcSEcCtD
Eletriptan—Malaise—Methotrexate—muscle cancer	0.000532	0.00124	CcSEcCtD
Eletriptan—Dizziness—Etoposide—muscle cancer	0.000532	0.00124	CcSEcCtD
Eletriptan—Immune system disorder—Doxorubicin—muscle cancer	0.00053	0.00124	CcSEcCtD
Eletriptan—Vertigo—Methotrexate—muscle cancer	0.00053	0.00124	CcSEcCtD
Eletriptan—Leukopenia—Methotrexate—muscle cancer	0.000528	0.00124	CcSEcCtD
Eletriptan—Chills—Doxorubicin—muscle cancer	0.000527	0.00123	CcSEcCtD
Eletriptan—Arrhythmia—Doxorubicin—muscle cancer	0.000524	0.00123	CcSEcCtD
Eletriptan—Alopecia—Doxorubicin—muscle cancer	0.000519	0.00121	CcSEcCtD
Eletriptan—Cough—Methotrexate—muscle cancer	0.000515	0.0012	CcSEcCtD
Eletriptan—Convulsion—Methotrexate—muscle cancer	0.000511	0.0012	CcSEcCtD
Eletriptan—Vomiting—Etoposide—muscle cancer	0.000511	0.0012	CcSEcCtD
Eletriptan—Rash—Etoposide—muscle cancer	0.000507	0.00119	CcSEcCtD
Eletriptan—Dermatitis—Etoposide—muscle cancer	0.000506	0.00118	CcSEcCtD
Eletriptan—Headache—Etoposide—muscle cancer	0.000504	0.00118	CcSEcCtD
Eletriptan—Flatulence—Doxorubicin—muscle cancer	0.000503	0.00118	CcSEcCtD
Eletriptan—Arthralgia—Methotrexate—muscle cancer	0.000502	0.00118	CcSEcCtD
Eletriptan—Myalgia—Methotrexate—muscle cancer	0.000502	0.00118	CcSEcCtD
Eletriptan—Tension—Doxorubicin—muscle cancer	0.000501	0.00117	CcSEcCtD
Eletriptan—Dysgeusia—Doxorubicin—muscle cancer	0.0005	0.00117	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000499	0.00117	CcSEcCtD
Eletriptan—Discomfort—Methotrexate—muscle cancer	0.000496	0.00116	CcSEcCtD
Eletriptan—Nervousness—Doxorubicin—muscle cancer	0.000496	0.00116	CcSEcCtD
Eletriptan—Back pain—Doxorubicin—muscle cancer	0.000494	0.00116	CcSEcCtD
Eletriptan—Muscle spasms—Doxorubicin—muscle cancer	0.000491	0.00115	CcSEcCtD
Eletriptan—Confusional state—Methotrexate—muscle cancer	0.000485	0.00114	CcSEcCtD
Eletriptan—Nausea—Etoposide—muscle cancer	0.000477	0.00112	CcSEcCtD
Eletriptan—Ill-defined disorder—Doxorubicin—muscle cancer	0.000474	0.00111	CcSEcCtD
Eletriptan—Nervous system disorder—Methotrexate—muscle cancer	0.000472	0.0011	CcSEcCtD
Eletriptan—Anaemia—Doxorubicin—muscle cancer	0.000472	0.0011	CcSEcCtD
Eletriptan—Agitation—Doxorubicin—muscle cancer	0.000469	0.0011	CcSEcCtD
Eletriptan—Skin disorder—Methotrexate—muscle cancer	0.000468	0.00109	CcSEcCtD
Eletriptan—Hyperhidrosis—Methotrexate—muscle cancer	0.000465	0.00109	CcSEcCtD
Eletriptan—Malaise—Doxorubicin—muscle cancer	0.000461	0.00108	CcSEcCtD
Eletriptan—Vertigo—Doxorubicin—muscle cancer	0.000459	0.00107	CcSEcCtD
Eletriptan—Anorexia—Methotrexate—muscle cancer	0.000459	0.00107	CcSEcCtD
Eletriptan—Syncope—Doxorubicin—muscle cancer	0.000458	0.00107	CcSEcCtD
Eletriptan—Leukopenia—Doxorubicin—muscle cancer	0.000457	0.00107	CcSEcCtD
Eletriptan—Palpitations—Doxorubicin—muscle cancer	0.000451	0.00106	CcSEcCtD
Eletriptan—Hypotension—Methotrexate—muscle cancer	0.00045	0.00105	CcSEcCtD
Eletriptan—Loss of consciousness—Doxorubicin—muscle cancer	0.000449	0.00105	CcSEcCtD
Eletriptan—Cough—Doxorubicin—muscle cancer	0.000446	0.00104	CcSEcCtD
Eletriptan—Convulsion—Doxorubicin—muscle cancer	0.000443	0.00104	CcSEcCtD
Eletriptan—Hypertension—Doxorubicin—muscle cancer	0.000441	0.00103	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000439	0.00103	CcSEcCtD
Eletriptan—Insomnia—Methotrexate—muscle cancer	0.000435	0.00102	CcSEcCtD
Eletriptan—Myalgia—Doxorubicin—muscle cancer	0.000435	0.00102	CcSEcCtD
Eletriptan—Arthralgia—Doxorubicin—muscle cancer	0.000435	0.00102	CcSEcCtD
Eletriptan—Anxiety—Doxorubicin—muscle cancer	0.000433	0.00101	CcSEcCtD
Eletriptan—Paraesthesia—Methotrexate—muscle cancer	0.000432	0.00101	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000432	0.00101	CcSEcCtD
Eletriptan—Discomfort—Doxorubicin—muscle cancer	0.00043	0.00101	CcSEcCtD
Eletriptan—Dyspnoea—Methotrexate—muscle cancer	0.000429	0.001	CcSEcCtD
Eletriptan—Somnolence—Methotrexate—muscle cancer	0.000428	0.001	CcSEcCtD
Eletriptan—Dry mouth—Doxorubicin—muscle cancer	0.000425	0.000995	CcSEcCtD
Eletriptan—Dyspepsia—Methotrexate—muscle cancer	0.000424	0.000992	CcSEcCtD
Eletriptan—Confusional state—Doxorubicin—muscle cancer	0.00042	0.000984	CcSEcCtD
Eletriptan—Decreased appetite—Methotrexate—muscle cancer	0.000419	0.000979	CcSEcCtD
Eletriptan—Oedema—Doxorubicin—muscle cancer	0.000417	0.000975	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000416	0.000973	CcSEcCtD
Eletriptan—Fatigue—Methotrexate—muscle cancer	0.000415	0.000971	CcSEcCtD
Eletriptan—Pain—Methotrexate—muscle cancer	0.000412	0.000963	CcSEcCtD
Eletriptan—Shock—Doxorubicin—muscle cancer	0.00041	0.00096	CcSEcCtD
Eletriptan—Nervous system disorder—Doxorubicin—muscle cancer	0.000409	0.000957	CcSEcCtD
Eletriptan—Tachycardia—Doxorubicin—muscle cancer	0.000407	0.000952	CcSEcCtD
Eletriptan—Skin disorder—Doxorubicin—muscle cancer	0.000405	0.000947	CcSEcCtD
Eletriptan—Hyperhidrosis—Doxorubicin—muscle cancer	0.000403	0.000943	CcSEcCtD
Eletriptan—Anorexia—Doxorubicin—muscle cancer	0.000397	0.00093	CcSEcCtD
Eletriptan—Feeling abnormal—Methotrexate—muscle cancer	0.000397	0.000928	CcSEcCtD
Eletriptan—Gastrointestinal pain—Methotrexate—muscle cancer	0.000394	0.000921	CcSEcCtD
Eletriptan—Hypotension—Doxorubicin—muscle cancer	0.00039	0.000911	CcSEcCtD
Eletriptan—Urticaria—Methotrexate—muscle cancer	0.000382	0.000895	CcSEcCtD
Eletriptan—Abdominal pain—Methotrexate—muscle cancer	0.000381	0.00089	CcSEcCtD
Eletriptan—Body temperature increased—Methotrexate—muscle cancer	0.000381	0.00089	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00038	0.000889	CcSEcCtD
Eletriptan—Insomnia—Doxorubicin—muscle cancer	0.000377	0.000882	CcSEcCtD
Eletriptan—Paraesthesia—Doxorubicin—muscle cancer	0.000374	0.000876	CcSEcCtD
Eletriptan—Dyspnoea—Doxorubicin—muscle cancer	0.000372	0.00087	CcSEcCtD
Eletriptan—Somnolence—Doxorubicin—muscle cancer	0.000371	0.000867	CcSEcCtD
Eletriptan—Dyspepsia—Doxorubicin—muscle cancer	0.000367	0.000859	CcSEcCtD
Eletriptan—Decreased appetite—Doxorubicin—muscle cancer	0.000362	0.000848	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00036	0.000842	CcSEcCtD
Eletriptan—Fatigue—Doxorubicin—muscle cancer	0.000359	0.000841	CcSEcCtD
Eletriptan—Constipation—Doxorubicin—muscle cancer	0.000357	0.000834	CcSEcCtD
Eletriptan—Pain—Doxorubicin—muscle cancer	0.000357	0.000834	CcSEcCtD
Eletriptan—Hypersensitivity—Methotrexate—muscle cancer	0.000355	0.00083	CcSEcCtD
Eletriptan—Asthenia—Methotrexate—muscle cancer	0.000345	0.000808	CcSEcCtD
Eletriptan—Feeling abnormal—Doxorubicin—muscle cancer	0.000344	0.000804	CcSEcCtD
Eletriptan—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000341	0.000798	CcSEcCtD
Eletriptan—Pruritus—Methotrexate—muscle cancer	0.000341	0.000797	CcSEcCtD
Eletriptan—Urticaria—Doxorubicin—muscle cancer	0.000331	0.000775	CcSEcCtD
Eletriptan—Abdominal pain—Doxorubicin—muscle cancer	0.00033	0.000771	CcSEcCtD
Eletriptan—Body temperature increased—Doxorubicin—muscle cancer	0.00033	0.000771	CcSEcCtD
Eletriptan—Diarrhoea—Methotrexate—muscle cancer	0.000329	0.000771	CcSEcCtD
Eletriptan—Dizziness—Methotrexate—muscle cancer	0.000318	0.000745	CcSEcCtD
Eletriptan—Hypersensitivity—Doxorubicin—muscle cancer	0.000307	0.000719	CcSEcCtD
Eletriptan—Vomiting—Methotrexate—muscle cancer	0.000306	0.000716	CcSEcCtD
Eletriptan—Rash—Methotrexate—muscle cancer	0.000304	0.00071	CcSEcCtD
Eletriptan—Dermatitis—Methotrexate—muscle cancer	0.000303	0.00071	CcSEcCtD
Eletriptan—Headache—Methotrexate—muscle cancer	0.000302	0.000706	CcSEcCtD
Eletriptan—Asthenia—Doxorubicin—muscle cancer	0.000299	0.0007	CcSEcCtD
Eletriptan—Pruritus—Doxorubicin—muscle cancer	0.000295	0.00069	CcSEcCtD
Eletriptan—Nausea—Methotrexate—muscle cancer	0.000286	0.000669	CcSEcCtD
Eletriptan—Diarrhoea—Doxorubicin—muscle cancer	0.000285	0.000667	CcSEcCtD
Eletriptan—Dizziness—Doxorubicin—muscle cancer	0.000276	0.000645	CcSEcCtD
Eletriptan—Vomiting—Doxorubicin—muscle cancer	0.000265	0.00062	CcSEcCtD
Eletriptan—Rash—Doxorubicin—muscle cancer	0.000263	0.000615	CcSEcCtD
Eletriptan—Dermatitis—Doxorubicin—muscle cancer	0.000263	0.000614	CcSEcCtD
Eletriptan—Headache—Doxorubicin—muscle cancer	0.000261	0.000611	CcSEcCtD
Eletriptan—Nausea—Doxorubicin—muscle cancer	0.000248	0.000579	CcSEcCtD
